![]() Minimally invasive devices Minimally Invasive Devices develops surgical tools that facilitate and enable the performance of minimally-invasive surgery. | ![]() Otomagnetics Otomagnetics is a company developing a non-invasive method to effectively deliver drugs to inner and middle ear without puncturing the eardrum. | ![]() Novostia Novostia is a company developing an artificial heart valve for patients of any age, including children. | ![]() Myra Vision Myra Vision (formerly known as Myra Medical) is a company that develops and delivers novel treatment technology for patients with glaucoma. | ||
Founding Date | Founding Date 1997 | Founding Date 2006 | Founding Date 2012 | Founding Date 2017 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Oakdale, US HQ | Locations Columbus, US HQ Cupertino, US | Locations Rockville, US HQ | Locations Neuchâtel, CH HQ Epalinges, CH | Locations Campbell, US HQ |
Employees | Employees 913% increase | Employees 3 | Employees 8 | Employees 16 | Employees 284% increase |
Funding | |||||
Latest funding round | Latest funding round $ 5m (over 8 years ago) | Latest funding round $ 14.1m (over 10 years ago) | Latest funding round $ 2.3m (over 6 years ago) | Latest funding round $ 2.8m (over 6 years ago) | Latest funding round $ 17m (almost 5 years ago) |
Total funding raised | Total funding raised $ 21.6m | Total funding raised $ 29m | Total funding raised $ 2.4m | Total funding raised $ 9.3m | Total funding raised $ 20.2m |

Minimally Invasive Devices develops surgical tools that facilitate and enable the performance of minimally-invasive surgery.
View company
Otomagnetics is a company developing a non-invasive method to effectively deliver drugs to inner and middle ear without puncturing the eardrum.
View company
Novostia is a company developing an artificial heart valve for patients of any age, including children.
View company
Myra Vision (formerly known as Myra Medical) is a company that develops and delivers novel treatment technology for patients with glaucoma.
View company